Literature DB >> 3397179

Ultrastructural localization of capsules, cell wall polysaccharide, cell wall proteins, and F antigen in pneumococci.

U B Skov Sørensen1, J Blom, A Birch-Andersen, J Henrichsen.   

Abstract

The localization of pneumococcal capsular and cell wall antigens was examined by immunoelectron microscopy. C polysaccharide (C-Ps), a common component of all pneumococci, was uniformly distributed on both the inside and outside of the cell walls. The thickness of the C-Ps varied with the strain. Encapsulated strains were covered by varied amounts of capsular polysaccharide concealing the C-Ps of the bacteria so as to render it inaccessible to anti-C-Ps antibodies. In addition to C-Ps, protein antigens were demonstrable on the surface of nonencapsulated pneumococci. The proteins were not masked by the C-Ps layer. An extra layer on the cell walls was conspicuous on electron micrographs of both rough and encapsulated pneumococci. The nature of this extra layer has not been disclosed. F antigen, another common antigen of pneumococci, was uniformly distributed on the surface of the plasma membranes. During the course of the experimental work a reproducible method of gold labeling immunoglobulins was developed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3397179      PMCID: PMC259497          DOI: 10.1128/iai.56.8.1890-1896.1988

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  Bacterial Morphology as Shown by the Electron Microscope: VI. Capsule, Cell-Wall and Inner Protoplasm of Pneumococcus, Type III.

Authors:  S Mudd; F Heinmets; T F Anderson
Journal:  J Bacteriol       Date:  1943-08       Impact factor: 3.490

2.  An electron microscopic study of the location of peptidoglycan in group A and C streptococcal cell walls.

Authors:  M Wagner; B Wagner
Journal:  J Gen Microbiol       Date:  1978-10

3.  Colloidal gold markers and probes for routine application in microscopy.

Authors:  S L Goodman; G M Hodges; L K Trejdosiewicz; D C Livingston
Journal:  J Microsc       Date:  1981-08       Impact factor: 1.758

4.  Protection of mice from infection with Streptococcus pneumoniae by anti-phosphocholine antibody.

Authors:  J Yother; C Forman; B M Gray; D E Briles
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

5.  Immunization, isolation of immunoglobulins, estimation of antibody titre.

Authors:  N Harboe; A Ingild
Journal:  Scand J Immunol Suppl       Date:  1973

6.  Pneumococcal Forssman antigen. A choline-containing lipoteichoic acid.

Authors:  E B Briles; A Tomasz
Journal:  J Biol Chem       Date:  1973-09-25       Impact factor: 5.157

7.  C-polysaccharide in a pneumococcal vaccine.

Authors:  U B Sørensen; J Henrichsen
Journal:  Acta Pathol Microbiol Immunol Scand C       Date:  1984-12

8.  Peptidoglycan cross-linking and teichoic acid attachment in Streptococcus pneumoniae.

Authors:  H Fischer; A Tomasz
Journal:  J Bacteriol       Date:  1985-07       Impact factor: 3.490

9.  The induction of meningeal inflammation by components of the pneumococcal cell wall.

Authors:  E Tuomanen; H Liu; B Hengstler; O Zak; A Tomasz
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

10.  THE FINE STRUCTURE OF DIPLOCOCCUS PNEUMONIAE.

Authors:  A TOMASZ; J D JAMIESON; E OTTOLENGHI
Journal:  J Cell Biol       Date:  1964-08       Impact factor: 10.539

View more
  23 in total

1.  Pneumococcal antigens and serum antibody responses in experimentally induced sinusitis.

Authors:  K M Westrin; A Freijd; P Stierna
Journal:  Eur Arch Otorhinolaryngol       Date:  1992       Impact factor: 2.503

2.  CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization.

Authors:  Richard Malley; Krzysztof Trzcinski; Amit Srivastava; Claudette M Thompson; Porter W Anderson; Marc Lipsitch
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-21       Impact factor: 11.205

3.  Western blot analysis of immunoglobulin G antibodies to pneumococcal protein antigens in healthy adults.

Authors:  J Renneberg; M Svinhufvud; K Prellner; P Christensen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-02       Impact factor: 3.267

4.  Mechanisms in the serotype-independent pneumococcal immunity induced in mice by intranasal vaccination with the cell wall polysaccharide.

Authors:  Ying-Jie Lu; Ian Chr Skovsted; Claudette M Thompson; Porter W Anderson; Richard Malley
Journal:  Microb Pathog       Date:  2009-07-03       Impact factor: 3.738

Review 5.  Immunogenicity and immunochemistry of Streptococcus pneumoniae capsular polysaccharides.

Authors:  J E van Dam; A Fleer; H Snippe
Journal:  Antonie Van Leeuwenhoek       Date:  1990-06       Impact factor: 2.271

6.  Comparison of antigen uptake by peritoneal macrophages and veiled cells from the thoracic duct using isotope-, FITC-, or gold-labelled antigen.

Authors:  J M Rhodes; B M Balfour; J Blom; R Agger
Journal:  Immunology       Date:  1989-11       Impact factor: 7.397

7.  Effect of capsulation of opportunistic pathogenic bacteria on binding of the pattern recognition molecules mannan-binding lectin, L-ficolin, and H-ficolin.

Authors:  Anders Krarup; Uffe B Skov Sørensen; Misao Matsushita; Jens C Jensenius; Steffen Thiel
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

8.  Broad antibody and T cell reactivity induced by a pneumococcal whole-cell vaccine.

Authors:  Kristin L Moffitt; Puja Yadav; Daniel M Weinberger; Porter W Anderson; Richard Malley
Journal:  Vaccine       Date:  2012-06-19       Impact factor: 3.641

9.  Mouse antibody to phosphocholine can protect mice from infection with mouse-virulent human isolates of Streptococcus pneumoniae.

Authors:  D E Briles; C Forman; M Crain
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

10.  Immunochemical analysis of the extracellular slime substance of Staphylococcus epidermidis.

Authors:  P Kotilainen; J Mäki; P Oksman; M K Viljanen; J Nikoskelainen; P Huovinen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-04       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.